{
    "componentChunkName": "component---src-templates-trial-trial-js",
    "path": "/trials/NCT00220675",
    "result": {"pageContext":{"pagePath":"/trials/NCT00220675","trial":{"nct_id":"NCT00220675","brief_title":"Erythropoietin Spinal Cord Compression Randomized Trial","official_title":"Recombinant Human Erythropoietin (r-HuEPO) in the Prevention of Neurologic Sequelae From Malignant Spinal Cord Compression: a Multi-Center, Placebo-Controlled, Phase 2 Randomized Study","about_trial":"To determine whether erythropoietin, steroids and radiotherapy is safe and feasible to administer to patients with malignant spinal cord compression.","age_from":19,"age_to":null,"ais_a":null,"ais_b":null,"ais_c":null,"ais_d":null,"ais_e":null,"time_since_injury_from":null,"time_since_injury_from_unit":null,"time_since_injury_to":null,"time_since_injury_to_unit":null,"healthy_volunteers":false,"inclusion_criteria":null,"study_type":"interventional","allocation":"Randomized","brief_description":"To determine whether erythropoietin, steroids and radiotherapy is safe and feasible to administer to patients with malignant spinal cord compression.","detailed_description":null,"final_testing_performed":null,"version_id":1,"emsci_trial":false,"curation_status":"uncurated","overall_recruitment_status":"ended","primary_intervention":null,"primary_benefit":null,"sex":"All","injury_level_from":null,"injury_level_to":null,"start_date":"2005-08","organization":"Sunnybrook Health Sciences Centre","benefits":[],"injuries":[],"interventions":[],"outcome_measures":[],"recovery_mechanisms":[],"published_at":"2024-04-16T22:20:58.000000Z","modified_at":"2024-04-16T22:20:58.000000Z"},"layout":"trial"}},
    "staticQueryHashes": ["1748999444"]}